United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery - Product Image

United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

  • ID: 4031188
  • Report
  • Region: United States
  • 488 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • DexCom Inc
  • Eli Lilly and Company
  • F
  • MORE
United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

The author's new report, "United States Diabetes Care Devices Market Outlook to 2022", provides key market data on the United States Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer HealthCare AG
  • Becton Dickinson and Co
  • DexCom Inc
  • Eli Lilly and Company
  • F
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Diabetes Care Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Diabetes Care Devices Market, United States

3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2022

3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015

3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015

3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2015

3.5 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2022

3.6 Diabetes Care Devices Market, United States, Volume (Units), 2008-2022

3.7 Diabetes Care Devices Market, United States, Volume (Units), 2008-2015

3.8 Diabetes Care Devices Market, United States, Volume (Units), 2015-2022

3.9 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2015

4 Glucose Monitoring Market, United States

4.1 Glucose Monitoring Market, United States, Revenue Mix ($m), 2015

4.2 Glucose Monitoring Market, United States, Segment Contribution (%), 2015

4.3 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015

4.4 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022

4.5 Glucose Monitoring Market, United States, Volume (Units), 2008-2015

4.6 Glucose Monitoring Market, United States, Volume (Units), 2015-2022

4.7 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015

4.8 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015

5 Insulin Delivery Market, United States

5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2015

5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2015

5.3 Insulin Delivery Market, United States, Revenue ($m), 2008-2015

5.4 Insulin Delivery Market, United States, Revenue ($m), 2015-2022

5.5 Insulin Delivery Market, United States, Volume (Units), 2008-2015

5.6 Insulin Delivery Market, United States, Volume (Units), 2015-2022

5.7 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2014-2015

5.8 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2015

6 Overview of Key Companies in United States, Diabetes Care Devices Market

6.1 Medtronic plc

6.2 Eli Lilly and Company

6.3 LifeScan Inc

6.4 Becton Dickinson and Co

6.5 Bayer HealthCare AG

6.6 Novo Nordisk A/S

6.7 Abbott Laboratories

6.8 Insulet Corp

6.9 DexCom Inc

6.10 F. Hoffmann-La Roche Ltd

6.11 Sanofi

6.12 Trividia Health Inc

7 Diabetes Care Devices Market Pipeline Products

8 Financial Deals Landscape

8.1 Acquisition

8.2 Debt Offerings

8.3 Equity Offerings

8.4 Partnerships

8.5 Private Equity

8.6 Venture Financing

9 Recent Developments

9.1 Corporate Communications

9.2 Financial Announcements

9.3 Government and Public Interest

9.4 Legal And Regulatory

9.5 Other Significant Developments

9.6 Product News

9.7 Strategy And Business Planning

10 Appendix

10.1 Research Methodology

10.2 Consulting

10.3 Contact Us

10.4 Disclaimer

1.1 List of Tables

Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022

Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015

Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022

Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015

Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022

Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2015

Table 9: Glucose Monitoring Market, United States, Segment Contribution (%), 2015

Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 11: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 13: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 14: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015

Table 15: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022

Table 16: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015

Table 17: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022

Table 18: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 19: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015

Table 20: Insulin Delivery Market, United States, Segment Contribution (%), 2015

Table 21: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 23: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 24: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 27: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015

Table 28: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022

Table 29: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015

Table 30: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015

Table 31: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022

Table 32: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022

Table 33: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 34: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2015

Table 35: Diabetes Care Devices Market Pipeline Products

Table 36: BioTelemetry Acquires Telcare Medical Supply and Associated Assets

Table 37: CRF Health Acquires Entra Health Systems

Table 38: Abbott Labs to Acquire Alere

Table 39: Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million

Table 40: MannKind May Sell Itself

Table 41: Teleflex Acquires Nostix

Table 42: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million

Table 43: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million

Table 44: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion

Table 45: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion

Table 46: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion

Table 47: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion

Table 48: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion

Table 49: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion

Table 50: Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019

Table 51: Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021

Table 52: Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026

Table 53: Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036

Table 54: Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046

Table 55: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes

Table 56: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028

Table 57: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028

Table 58: Insulet Raises Private Placement of Senior Notes for USD300 Million

Table 59: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018

Table 60: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019

Table 61: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021

Table 62: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026

Table 63: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044

Table 64: Echo Therapeutics Raises USD3.4 Million in Second and Final Tranche of Private Placement of Notes and Warrants

Table 65: Echo Therapeutics Raises USD1.8 Million in First Tranche Private Placement of Notes and Warrants

Table 66: GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs

Table 67: ConvaTec Raises USD1.8 Billion in IPO

Table 68: Mannkind Prices Shares Issue for USD50 Million

Table 69: Valeritas Raises USD25 Million in Private Placement of Shares

Table 70: Senseonics Raises USD45 Million in Public Offering of Shares

Table 71: PharmaCyte Biotech Raises USD1 Million in Private Placement of shares

Table 72: Defymed Enters into Agreement with Semma Therapeutics

Table 73: Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation

Table 74: Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies

Table 75: WellDoc Enters into Agreement with LifeScan

Table 76: Sanofi and Verily Life Sciences Form Joint Venture

Table 77: JDRF Enters into Co-Development Agreement with Arecor

Table 78: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies

Table 79: Profil Institute for Clinical Research Enters into Agreement with mySugr

Table 80: Diasend Partners with Abbott Labs

Table 81: Medtronic and Qualcomm Life Enter into Co-Development Agreement

Table 82: InSpark Technologies Enters into Agreement with Atlanta Diabetes Associates and East Carolina Diabetes and Obesity Institute

Table 83: Metabolon Enters into Licensing Agreement with Synlab

Table 84: LifeScan Enters into Agreement with WellDoc

Table 85: Insulet Enters into Licensing Agreement with Mode AGC

Table 86: Senseonics Enters into Agreement with Diasend

Table 87: Insulet Enters into Co-Development Agreement with Eli Lilly

Table 88: Warburg Pincus to Invest in Hygiena

Table 89: Intuity Medical Raises USD40 Million in Series 3 Financing

Table 90: Bigfoot Biomedical Raises USD35.5 Million in Series A Financing

Table 91: Glooko Raises USD8 Million in Financing Round

Table 92: Dance Biopharm Raises USD0.625 Million in Venture Financing

Table 93: Eccrine Systems Raises USD4.56 Million in Venture Financing

Table 94: Common Sensing Raises USD1.6 Million in Financing Round

Table 95: Optiscan Biomedical Raises USD29.5 Million in Financing Round

Table 96: DexCom Raises USD7.2 Million in Venture Financing

Table 97: Livongo Health Raises USD44.5 Million in Series C Financing Round

Table 98: WellDoc Raises USD7.5 Million in Extended Series B Financing

Table 99: Epinex Diagnostics Raises USD0.1 Million in Venture Financing

Table 100: Bigfoot Biomedical Raises USD2.37 Million in Venture Financing

1.2 List of Figures

Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022

Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015

Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2015

Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 5: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 6: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022

Figure 7: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015

Figure 8: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022

Figure 9: Diabetes Care Devices Market, United States, Company Share (%) 2015

Figure 10: Glucose Monitoring Market, United States, Revenue Mix ($m), 2015

Figure 11: Glucose Monitoring Market, United States, Segment Contribution (%), 2015

Figure 12: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 13: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 14: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 15: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 16: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015

Figure 17: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022

Figure 18: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015

Figure 19: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022

Figure 20: Glucose Monitoring Market, United States, Company Share (%) 2015

Figure 21: Insulin Delivery Market, United States, Revenue Mix ($m), 2015

Figure 22: Insulin Delivery Market, United States, Segment Contribution (%), 2015

Figure 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 24: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 27: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 28: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 29: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015

Figure 30: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022

Figure 31: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015

Figure 32: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015

Figure 33: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022

Figure 34: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022

Figure 35: Insulin Delivery Market, United States, Company Share (%) 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Medtronic plc
- Eli Lilly and Company
- LifeScan Inc
- Becton Dickinson and Co
- Bayer HealthCare AG
- Novo Nordisk A/S
- Abbott Laboratories
- Insulet Corp
- DexCom Inc
- F
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll